Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

How does baricitinib compare in RA patients at risk of VTE?
03 Jul 2026
bởiStephen Padilla
Treatment with baricitinib misses the noninferiority mark against tumour necrosis factor inhibitors (TNFi) in active rheumatoid arthritis (RA) patients at risk for venous thromboembolism (VTE) with high baseline disease activity, reports a study.
03 Jul 2026

Novel extended-release tablet superior to febuxostat at reducing SUA levels
03 Jul 2026
bởiStephen Padilla
An extended-release formulation, HR091506, performs better than febuxostat immediate release in lowering urate levels in patients with gout and hyperuricaemia, as shown in a phase III trial.
03 Jul 2026

Rucaparib extends time to subsequent therapy in advanced ovarian cancer
02 Jul 2026
bởiStephen Padilla
In patients with newly diagnosed advanced ovarian cancer, treatment with rucaparib delays the median time to first and second subsequent anticancer therapy for almost 1 year relative to placebo, according to a study presented at ESMO Gyn 2026.
02 Jul 2026






